Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bellanger

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Southern Medical Journal|December 1, 1996
Delayed posttraumatic tamponadeD Bellanger, D J Nikas, J E Freeman, et al.
Surgical Endoscopy|July 5, 2002
Tissue attachment strength of prosthetic meshes used in ventral and incisional hernia repair. A study in the New Zealand White rabbit adhesion modelK A LeBlanc, D Bellanger, K V Rhynes, et al.
Leukemia|September 20, 2013
Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemiaD Bellanger, V Jacquemin, M Chopin, et al.
Oncogene|September 19, 2012
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumorG-A Franzetti, K Laud-Duval, D Bellanger, et al.
Leukemia|August 15, 2017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profilingE I Andersson, S Pützer, B Yadav, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Southern Medical Journal|December 1, 1996
Delayed posttraumatic tamponadeD Bellanger, D J Nikas, J E Freeman, et al.
Surgical Endoscopy|July 5, 2002
Tissue attachment strength of prosthetic meshes used in ventral and incisional hernia repair. A study in the New Zealand White rabbit adhesion modelK A LeBlanc, D Bellanger, K V Rhynes, et al.
Leukemia|September 20, 2013
Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemiaD Bellanger, V Jacquemin, M Chopin, et al.
Oncogene|September 19, 2012
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumorG-A Franzetti, K Laud-Duval, D Bellanger, et al.
Leukemia|August 15, 2017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profilingE I Andersson, S Pützer, B Yadav, et al.
Pageof 1